Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Liver Diseases

  Free Subscription


Articles published in J Gastroenterol Hepatol

Retrieve available abstracts of 237 articles:
HTML format
Text format



Single Articles


    April 2018
  1. KODAMA K, Kawaoka T, Aikata H, Uchikawa S, et al
    Comparison of clinical outcome of hepatic arterial infusion chemotherapy and sorafenib for advanced hepatocellular carcinoma according to macrovascular invasion and transcatheter arterial chemoembolization refractory status.
    J Gastroenterol Hepatol. 2018 Apr 12. doi: 10.1111/jgh.14152.
    PubMed     Text format     Abstract available


  2. LIN YX, Hu HJ, Li FY, Jia QB, et al
    Hepatobiliary and Pancreatic: Biliary reoperation for recurrent intrahepatic stones in patients with polysplenia syndrome.
    J Gastroenterol Hepatol. 2018 Apr 6. doi: 10.1111/jgh.14137.
    PubMed     Text format    


  3. YANG MJ, Kim JH, Kim DJ, Hwang JC, et al
    Hepatobiliary and Pancreatic: EUS-guided reintervention for extraluminal stent migration after EUS-guided hepaticogastrostomy.
    J Gastroenterol Hepatol. 2018;33:772.
    PubMed     Text format    


  4. KANG MK, Kim TN
    Hepatobiliary and Pancreatic: Hepatocellular carcinoma diagnosed by proptosis due to metastatic orbital mass.
    J Gastroenterol Hepatol. 2018;33:773.
    PubMed     Text format    


    March 2018
  5. CHAN WK, Mustapha NRN, Mahadeva S, Wong VW, et al
    Can the same controlled attenuation parameter cut-offs be used for M and XL probes for diagnosing hepatic steatosis?
    J Gastroenterol Hepatol. 2018 Mar 30. doi: 10.1111/jgh.14150.
    PubMed     Text format     Abstract available


  6. TANDON P, Bishay K, Fisher S, Yelle D, et al
    Comparison of Clinical Outcomes Between Variceal and Non-Variceal Gastrointestinal Bleeding in Patients with Cirrhosis.
    J Gastroenterol Hepatol. 2018 Mar 30. doi: 10.1111/jgh.14147.
    PubMed     Text format     Abstract available


  7. PARK SW, Jun CH, Choi SK, Kim HJ, et al
    Hepatobiliary and Pancreatic: A black liver of Dubin-Johnson syndrome.
    J Gastroenterol Hepatol. 2018;33:562.
    PubMed     Text format    


  8. VANBRUGGHE C, Tabchouri N, Louis G, Del Grande J, et al
    Hepatobiliary and Pancreatic: A rare form of autoimmune pancreatitis mimicking mixed-type intraductal papillary mucinous neoplasm.
    J Gastroenterol Hepatol. 2018;33:563.
    PubMed     Text format    


    February 2018
  9. KIM TH, Ku DH, Um SH, Lee HA, et al
    How can we improve the performance of MELDNa score in patients with HBV-related decompensated liver cirrhosis commencing antiviral treatment?
    J Gastroenterol Hepatol. 2018 Feb 20. doi: 10.1111/jgh.14128.
    PubMed     Text format     Abstract available


  10. WIGG AJ, Chin JK, Muller KR, Ramachandran J, et al
    A Chronic Disease Management Model for Cirrhosis is Cost-Effective: Analysis of a Randomized Controlled Trial.
    J Gastroenterol Hepatol. 2018 Feb 20. doi: 10.1111/jgh.14127.
    PubMed     Text format     Abstract available


  11. YAMADA T, Nakanishi Y, Okamura K, Tsuchikawa T, et al
    Impact of serum CA19-9 level on prognosis and prediction of lymph node metastasis in patients with intrahepatic cholangiocarcinoma.
    J Gastroenterol Hepatol. 2018 Feb 10. doi: 10.1111/jgh.14124.
    PubMed     Text format     Abstract available


  12. DOI H, Hayashi E, Arai J, Tojo M, et al
    Advanced cirrhosis drives enhanced B-cell differentiation resulting in hyperglobulinemia.
    J Gastroenterol Hepatol. 2018 Feb 10. doi: 10.1111/jgh.14123.
    PubMed     Text format     Abstract available


  13. HACZEYNI F, Yeh MM, Ioannou GN, Leclercq IA, et al
    Mouse Models Of Nonalcoholic Steatohepatitis: A Reflection On Recent Literature.
    J Gastroenterol Hepatol. 2018 Feb 9. doi: 10.1111/jgh.14122.
    PubMed     Text format     Abstract available


  14. OKUNO N, Hara K, Mizuno N, Kuwahara T, et al
    Efficacy of the 6-mm FCSEMS during EUS-guided hepaticogastrostomy as a primary biliary drainage for the cases estimated difficult ERCP: a prospective clinical study.
    J Gastroenterol Hepatol. 2018 Feb 9. doi: 10.1111/jgh.14112.
    PubMed     Text format     Abstract available


  15. WANG Q, Wang G, Wang Y, Liu C, et al
    ALKBH3 expression is associated with tumor recurrence and unfavorable prognosis in hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2018 Feb 7. doi: 10.1111/jgh.14117.
    PubMed     Text format     Abstract available


  16. ZHANG LH, Tai Y, Tong H, Lei XJ, et al
    Hepatobiliary and Pancreatic: Rare cause of obstructive jaundice by Trichosporon asahii.
    J Gastroenterol Hepatol. 2018;33:338.
    PubMed     Text format    


  17. JAISWAL P, Jaiswal R, Attar BM, Dedania B, et al
    Hepatobiliary and Pancreatic: Massive hepatic cystic echinococcosis compressing inferior vena cava.
    J Gastroenterol Hepatol. 2018;33:339.
    PubMed     Text format    


    January 2018
  18. MANCEBO A, Varela M, Gonzalez-Dieguez ML, Navascues CA, et al
    Incidence and Risk Factors Associated with Hepatocellular Carcinoma Surveillance Failure.
    J Gastroenterol Hepatol. 2018 Jan 31. doi: 10.1111/jgh.14108.
    PubMed     Text format     Abstract available


  19. ZHANG F, Zhang J, Li X, Li B, et al
    The Notch signaling pathway regulates cell cycle in proliferating hepatocytes involved in liver regeneration.
    J Gastroenterol Hepatol. 2018 Jan 31. doi: 10.1111/jgh.14110.
    PubMed     Text format     Abstract available


  20. KAO JH, Yu ML, Chen CY, Peng CY, et al
    Twelve-week Ravidasvir plus ritonavir-boosted Danoprevir and ribavirin for non-cirrhotic HCV genotype 1 patients: A phase 2 study.
    J Gastroenterol Hepatol. 2018 Jan 18. doi: 10.1111/jgh.14096.
    PubMed     Text format     Abstract available


  21. KIM NH, Lee T, Cho YK, Kim BI, et al
    Impact of clinically evident portal hypertension on clinical outcome of patients with hepatocellular carcinoma treated by transarterial chemoembolization.
    J Gastroenterol Hepatol. 2018 Jan 3. doi: 10.1111/jgh.14083.
    PubMed     Text format     Abstract available


  22. FANG X, Liu LW, Dong J, Zhang J, et al
    A study about immunomodulatory effect and efficacy and prognosis of hUCMSCs in patients with CHB-induced decompensated liver cirrhosis.
    J Gastroenterol Hepatol. 2018 Jan 2. doi: 10.1111/jgh.14081.
    PubMed     Text format     Abstract available


  23. HARIMOTO N, Yugawa K, Ikegami T, Ohira M, et al
    Hepatobiliary and Pancreatic: Pregnancy induced hepatic veno-occlusive disease requiring liver transplantation.
    J Gastroenterol Hepatol. 2018;33:9.
    PubMed     Text format    


  24. CRIMI F, Guido M, Pomerri F
    Hepatobiliary and Pancreatic: Hepatic nodules in a patient with familial adenomatous polyposis and colorectal adenocarcinoma.
    J Gastroenterol Hepatol. 2018;33:8.
    PubMed     Text format    


    December 2017
  25. KAWASHITA Y, Morine Y, Saito Y, Takasu C, et al
    Role of HSF1 expression in the microenvironment of intrahepatic cholangiocarcinomas.
    J Gastroenterol Hepatol. 2017 Dec 26. doi: 10.1111/jgh.14078.
    PubMed     Text format     Abstract available


  26. ATSUKAWA M, Tsubota A, Kato K, Abe H, et al
    Analysis of factors predicting the response to tolvaptan in patients with liver cirrhosis and hepatic edema.
    J Gastroenterol Hepatol. 2017 Dec 7. doi: 10.1111/jgh.14047.
    PubMed     Text format     Abstract available


  27. ZHOU LY, Ma YJ, Tian F
    Hepatobiliary and Pancreatic: Management of bleeding colonic varices in liver disease.
    J Gastroenterol Hepatol. 2017;32:1913.
    PubMed     Text format    


  28. CHOUDHURY A, Kumar M, Sharma BC, Maiwall R, et al
    Systemic inflammatory response syndrome in acute-on-chronic liver failure: Relevance of 'golden window': A prospective study.
    J Gastroenterol Hepatol. 2017;32:1989-1997.
    PubMed     Text format     Abstract available


    November 2017
  29. HIRAOKA A, Otsuka Y, Kawasaki H, Izumoto H, et al
    Impact of muscle volume and function decline in patients undergoing surgical resection for hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2017 Nov 28. doi: 10.1111/jgh.14058.
    PubMed     Text format     Abstract available


  30. LI G, Brocker CN, Xie C, Yan T, et al
    Hepatic PPARalpha mediates the major metabolic effects of Wy-14643.
    J Gastroenterol Hepatol. 2017 Nov 15. doi: 10.1111/jgh.14046.
    PubMed     Text format     Abstract available


  31. SCHLEVOGT B, Rehkamper J, Hild B, Schmidt HH, et al
    Hepatobiliary and Pancreatic: Fulminant liver failure from diffuse leukemoid hepatic infiltration of melanoma.
    J Gastroenterol Hepatol. 2017;32:1795.
    PubMed     Text format    


  32. LLOP E, Lopez M, de la Revilla J, Fernandez N, et al
    Validation of noninvasive methods to predict the presence of gastroesophageal varices in a cohort of patients with compensated advanced chronic liver disease.
    J Gastroenterol Hepatol. 2017;32:1867-1872.
    PubMed     Text format     Abstract available


  33. HIROOKA M, Koizumi Y, Imai Y, Nakamura Y, et al
    Clinical utility of multipolar ablation with a 3-D simulator system for patients with liver cancer.
    J Gastroenterol Hepatol. 2017;32:1852-1858.
    PubMed     Text format     Abstract available


    October 2017
  34. ARAI J, Goto K, Stephanou A, Tanoue Y, et al
    Predominance of regorafenib over sorafenib: restoration of membrane-bound MICA in hepatocellular carcinoma cells.
    J Gastroenterol Hepatol. 2017 Oct 21. doi: 10.1111/jgh.14029.
    PubMed     Text format     Abstract available


  35. OTANI I, Oka S, Tanaka S, Tsuboi A, et al
    Clinical significance of small-bowel villous edema in patients with liver cirrhosis-a capsule endoscopy study.
    J Gastroenterol Hepatol. 2017 Oct 10. doi: 10.1111/jgh.14016.
    PubMed     Text format     Abstract available


  36. CHOE EY, Lee YH, Choi YJ, Huh BW, et al
    Waist-to-calf ratio is an independent predictor of hepatic steatosis and fibrosis patients with type 2 diabetes.
    J Gastroenterol Hepatol. 2017 Oct 8. doi: 10.1111/jgh.14011.
    PubMed     Text format     Abstract available


  37. SHI SH, Feng XN, Wang ZY, Sun K, et al
    Pyogenic liver abscess related to intrahepatic bile duct stones: difficulties in infectious control and diagnosis of concomitant cholangiocarcinoma.
    J Gastroenterol Hepatol. 2017 Oct 6. doi: 10.1111/jgh.14010.
    PubMed     Text format     Abstract available


  38. DING F, Li Q, Duan X, Ye J, et al
    Hepatobiliary and Pancreatic: Ruptured aneurysm of intra-hepatic portal vein causing obstructive jaundice.
    J Gastroenterol Hepatol. 2017;32:1666.
    PubMed     Text format    


  39. GILES H, Ross A, Gearry RB
    Gastrointestinal: Hepatic abscess after botulinum toxin type-A therapy for achalasia.
    J Gastroenterol Hepatol. 2017;32:1663.
    PubMed     Text format    


  40. NGUYEN BD
    Hepatobiliary and Pancreatic: Hepatic necrobiotic xanthogranuloma.
    J Gastroenterol Hepatol. 2017;32:1667.
    PubMed     Text format    


  41. ZHENG YX, Zhong X, Li YJ, Fan XG, et al
    Performance of scoring systems to predict mortality of patients with acute-on-chronic liver failure: A systematic review and meta-analysis.
    J Gastroenterol Hepatol. 2017;32:1668-1678.
    PubMed     Text format     Abstract available


  42. PUIGVEHI M, Broquetas T, Coll S, Garcia-Retortillo M, et al
    Impact of anthropometric features on the applicability and accuracy of FibroScan((R)) (M and XL) in overweight/obese patients.
    J Gastroenterol Hepatol. 2017;32:1746-1753.
    PubMed     Text format     Abstract available


  43. LIN YJ, Gao XM, Pan WW, Gao S, et al
    A model to predict the onset of non-alcoholic fatty liver disease within 2 years in elderly adults.
    J Gastroenterol Hepatol. 2017;32:1739-1745.
    PubMed     Text format     Abstract available


    September 2017
  44. TADA T, Kumada T, Toyoda H, Kobayashi N, et al
    Hepatitis B virus core-related antigen levels predict progression to liver cirrhosis in hepatitis B carriers.
    J Gastroenterol Hepatol. 2017 Sep 15. doi: 10.1111/jgh.13989.
    PubMed     Text format     Abstract available


  45. SEO YS, Park SY, Kim MY, Kim SG, et al
    Serum cystatin C level is an excellent predictor of mortality in patients with cirrhotic ascites.
    J Gastroenterol Hepatol. 2017 Sep 14. doi: 10.1111/jgh.13983.
    PubMed     Text format     Abstract available


  46. ZHANG B, Zhang CG, Ji LH, Zhao G, et al
    Estrogen receptor beta selective agonist ameliorates liver cirrhosis in rats by inhibiting the activation and proliferation of hepatic stellate cells.
    J Gastroenterol Hepatol. 2017 Sep 7. doi: 10.1111/jgh.13976.
    PubMed     Text format     Abstract available


  47. ESO Y, Takai A, Arasawa S, Ueda Y, et al
    Hepatobiliary and Pancreatic: Granulomatous hepatitis due to disseminated bacillus Calmette-Guerin disease.
    J Gastroenterol Hepatol. 2017;32:1538.
    PubMed     Text format    


  48. LIU PC, Wu MS, Hsieh MC, Suk FM, et al
    Hepatobiliary and Pancreatic: Development from gallbladder stone to gallstone ileus.
    J Gastroenterol Hepatol. 2017;32:1539.
    PubMed     Text format    


  49. LV XH, Wang CH, Xie Y
    Arsenic trioxide combined with transarterial chemoembolization for primary liver cancer: A meta-analysis.
    J Gastroenterol Hepatol. 2017;32:1540-1547.
    PubMed     Text format     Abstract available


  50. JIA Z, Paz-Fumagalli R, Frey G, Sella DM, et al
    Single-institution experience of radioembolization with yttrium-90 microspheres for unresectable metastatic neuroendocrine liver tumors.
    J Gastroenterol Hepatol. 2017;32:1617-1623.
    PubMed     Text format     Abstract available


  51. CRESCI GA, Glueck B, McMullen MR, Xin W, et al
    Prophylactic tributyrin treatment mitigates chronic-binge ethanol-induced intestinal barrier and liver injury.
    J Gastroenterol Hepatol. 2017;32:1587-1597.
    PubMed     Text format     Abstract available


    August 2017
  52. GERAGE AM, Ritti-Dias RM, Balagopal B, de Oliveira Conceicao RD, et al
    Physical activity levels and hepatic steatosis: a longitudinal follow up study in adults.
    J Gastroenterol Hepatol. 2017 Aug 30. doi: 10.1111/jgh.13965.
    PubMed     Text format     Abstract available


  53. CHIRAPONGSATHORN S, Bunraksa W, Chaiprasert A, Punpanich D, et al
    Adding C-reactive protein and procalcitonin to the MELD score improves mortality prediction in patients with complications of cirrhosis.
    J Gastroenterol Hepatol. 2017 Aug 25. doi: 10.1111/jgh.13928.
    PubMed     Text format     Abstract available


  54. AMPUERO J, Montoliu C, Simon-Talero M, Aguilera V, et al
    Minimal hepatic encephalopathy identifies patients at risk of faster cirrhosis progression.
    J Gastroenterol Hepatol. 2017 Aug 2. doi: 10.1111/jgh.13917.
    PubMed     Text format     Abstract available


  55. HO CM, Wu CH, Liau JY
    Hepatobiliary and Pancreatic: Biliary intra-epithelial neoplasia.
    J Gastroenterol Hepatol. 2017;32:1424.
    PubMed     Text format    


  56. MATSUMURA K, Hashimoto D, Umezaki N, Nakagawa S, et al
    Hepatobiliary and Pancreatic: Portal vein stent for local recurrence of bile duct cancer.
    J Gastroenterol Hepatol. 2017;32:1425.
    PubMed     Text format    


    July 2017
  57. DE SANTIS A, Nardelli S, Bassanelli C, Lupo M, et al
    The modification of splenic stiffness on acoustic radiation force impulse parallels the variation of portal pressure induced by transjugular intrahepatic portosystemic shunt.
    J Gastroenterol Hepatol. 2017 Jul 28. doi: 10.1111/jgh.13907.
    PubMed     Text format     Abstract available


  58. ELNEGOULY M, Umgelter K, Safi W, Hapfelmeier A, et al
    Elevated Cardiac Troponin T in Cirrhotic Patients with Emergency Care Admissions is Associated with Mortality.
    J Gastroenterol Hepatol. 2017 Jul 20. doi: 10.1111/jgh.13902.
    PubMed     Text format     Abstract available


  59. KIMER N, Pedersen JS, Tavenier J, Christensen JE, et al
    Rifaximin has minor effects on bacterial composition, inflammation and bacterial translocation in cirrhosis; A randomized trial.
    J Gastroenterol Hepatol. 2017 Jul 3. doi: 10.1111/jgh.13852.
    PubMed     Text format     Abstract available


  60. ZHONG X, Liu H
    Honokiol attenuates Diet-Induced Nonalcoholic Steatohepatitis by regulating macrophage polarization through activating PPARgamma.
    J Gastroenterol Hepatol. 2017 Jul 2. doi: 10.1111/jgh.13853.
    PubMed     Text format     Abstract available


  61. COSTA JM, Costa D, Vieira F, Rolanda C, et al
    Hepatobiliary and Pancreatic: Giant hepatomegaly from hepatic hemagiomatosis.
    J Gastroenterol Hepatol. 2017;32:1285.
    PubMed     Text format    


  62. AGARWAL J, Hasan A, Mehrotra M
    Hepatobiliary and Pancreatic: Hepatogastric fistula.
    J Gastroenterol Hepatol. 2017;32:1284.
    PubMed     Text format    


  63. MORIKAWA M, Suzuki H, Obata-Yasuoka M, Kasai M, et al
    Association of antenatal antithrombin activity with perinatal liver dysfunction: A prospective multicenter study.
    J Gastroenterol Hepatol. 2017;32:1378-1386.
    PubMed     Text format     Abstract available


  64. LOONG TC, Wei JL, Leung JC, Wong GL, et al
    Application of the combined FibroMeter vibration-controlled transient elastography algorithm in Chinese patients with non-alcoholic fatty liver disease.
    J Gastroenterol Hepatol. 2017;32:1363-1369.
    PubMed     Text format     Abstract available


    June 2017
  65. KIM BS, Seo YS, Kim YS, Lee CH, et al
    Reduced risk of hepatocellular carcinoma by achieving a subcirrhotic liver stiffness through antiviral agents in hepatitis B virus-related advanced fibrosis or cirrhosis.
    J Gastroenterol Hepatol. 2017 Jun 30. doi: 10.1111/jgh.13854.
    PubMed     Text format     Abstract available


  66. FUJITA K, Niki T, Nomura T, Oura K, et al
    Serum galectin-9 levels are correlated to liver fibrosis regardless of chronic inflammation or hepatocellular carcinoma complications.
    J Gastroenterol Hepatol. 2017 Jun 15. doi: 10.1111/jgh.13851.
    PubMed     Text format     Abstract available


  67. SZKLARUK J, Kaya D, Wei W
    Evaluation of the Added Value of Imaging the Pelvis in Patients with Hepatocellular Cancer.
    J Gastroenterol Hepatol. 2017 Jun 14. doi: 10.1111/jgh.13847.
    PubMed     Text format     Abstract available


  68. KIM BH, Lim YS, Kim EY, Kong HJ, et al
    Temporal Improvement in Survival of Patients with Hepatocellular Carcinoma in a Hepatitis B Virus-Endemic Population.
    J Gastroenterol Hepatol. 2017 Jun 14. doi: 10.1111/jgh.13848.
    PubMed     Text format     Abstract available


  69. ZHANG X, Li J, Shen F, Lau WY, et al
    Significance of presence of microvascular invasion in specimens obtained after surgical treatment of hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2017 Jun 6. doi: 10.1111/jgh.13843.
    PubMed     Text format     Abstract available


  70. LING QA, Yo J, Gerstenmaier JF, Kemp W, et al
    Hepatobiliary and Pancreatic: Hepatic and mesenteric aneurysms with biloma formation.
    J Gastroenterol Hepatol. 2017;32:1134.
    PubMed     Text format    


  71. BERTRAIS S, Boursier J, Ducancelle A, Oberti F, et al
    Prognostic durability of liver fibrosis tests and improvement in predictive performance for mortality by combining tests.
    J Gastroenterol Hepatol. 2017;32:1240-1249.
    PubMed     Text format     Abstract available


    May 2017
  72. LIU CH, Liu CJ, Hong CM, Su TH, et al
    A noninvasive diagnosis of hepatic fibrosis by BioFibroScore(R) in chronic hepatitis C patients.
    J Gastroenterol Hepatol. 2017 May 26. doi: 10.1111/jgh.13834.
    PubMed     Text format     Abstract available


  73. SVIKLANE L, Olmane E, Dzerve Z, Kupcs K, et al
    Fatty liver index and hepatic steatosis index predict non-alcoholic fatty liver disease in type 1 diabetes.
    J Gastroenterol Hepatol. 2017 May 2. doi: 10.1111/jgh.13814.
    PubMed     Text format     Abstract available


  74. KIM JH, Lim KS, Min YW, Lee H, et al
    Proton pump inhibitors do not increase the risk for recurrent spontaneous bacterial peritonitis in patients with cirrhosis.
    J Gastroenterol Hepatol. 2017;32:1064-1070.
    PubMed     Text format     Abstract available


  75. MAIA L, Ferreira JM, Pedroto I
    Hepatobiliary and Pancreatic: Unusual cause of acute pancreatitis.
    J Gastroenterol Hepatol. 2017;32:948.
    PubMed     Text format    


  76. JUN DW, Kim SG, Park SH, Jin SY, et al
    External validation of the non-alcoholic fatty liver disease fibrosis score for assessing advanced fibrosis in Korean patients.
    J Gastroenterol Hepatol. 2017;32:1094-1099.
    PubMed     Text format     Abstract available


  77. PARKER R, Hodson J, Rowe IAC
    Systematic review: Current evidence in non-alcoholic fatty liver disease lacks relevance to patients with advanced fibrosis.
    J Gastroenterol Hepatol. 2017;32:950-956.
    PubMed     Text format     Abstract available


  78. RASHID HO, Kim HK, Junjappa R, Kim HR, et al
    Endoplasmic reticulum stress in the regulation of liver diseases: Involvement of Regulated IRE1alpha and beta-dependent decay and miRNA.
    J Gastroenterol Hepatol. 2017;32:981-991.
    PubMed     Text format     Abstract available


    April 2017
  79. ITO K, Murotani K, Nakade Y, Inoue T, et al
    Serum WFA+ -M2BP levels predict liver fibrosis, development of hepatocellular carcinoma, and overall survival: A meta-analysis.
    J Gastroenterol Hepatol. 2017 Apr 12. doi: 10.1111/jgh.13802.
    PubMed     Text format     Abstract available


  80. BASIR DN, Telisinghe PU, Bickle I, Chong VH, et al
    Hepatobiliary and Pancreatic: Malignant rhabdoid tumor of the liver.
    J Gastroenterol Hepatol. 2017;32:738.
    PubMed     Text format    


  81. LOURENCO LC, Horta DV, Reis J
    Hepatobiliary and Pancreatic: Gastric outlet obstruction from pancreatitis-induced intramural duodenal haematoma.
    J Gastroenterol Hepatol. 2017;32:739.
    PubMed     Text format    


  82. LIU PH, Hsu CY, Hsia CY, Lee YH, et al
    ALBI and PALBI grade predict survival for HCC across treatment modalities and BCLC stages in the MELD Era.
    J Gastroenterol Hepatol. 2017;32:879-886.
    PubMed     Text format     Abstract available


  83. NJEI B, McCarty TR, Laine L
    Early transjugular intrahepatic portosystemic shunt in US patients hospitalized with acute esophageal variceal bleeding.
    J Gastroenterol Hepatol. 2017;32:852-858.
    PubMed     Text format     Abstract available


    March 2017
  84. JIANG T, Du F, Qin N, Lu Q, et al
    Systematical analyses of variants in DNase I hypersensitive sites identified two novel hepatocellular carcinoma susceptibility loci among Chinese population.
    J Gastroenterol Hepatol. 2017 Mar 20. doi: 10.1111/jgh.13790.
    PubMed     Text format     Abstract available


  85. KUO YH, Wang JH, Hung CH, Rau KM, et al
    The ALBI grade predicts the prognosis of patients with advanced hepatocellular carcinoma received sorafenib.
    J Gastroenterol Hepatol. 2017 Mar 11. doi: 10.1111/jgh.13783.
    PubMed     Text format     Abstract available


  86. HSIEH YC, Lee KC, Chen PH, Su CW, et al
    Acute kidney injury predicts mortality in cirrhotic patients with gastric variceal bleeding.
    J Gastroenterol Hepatol. 2017 Mar 8. doi: 10.1111/jgh.13777.
    PubMed     Text format     Abstract available


  87. SATO M, Tateishi R, Yasunaga H, Matsui H, et al
    Mortality and hemorrhagic complications associated with radiofrequency ablation for treatment of hepatocellular carcinoma in patients on hemodialysis for end-stage renal disease: a nationwide survey.
    J Gastroenterol Hepatol. 2017 Mar 7. doi: 10.1111/jgh.13780.
    PubMed     Text format     Abstract available


  88. MIYATA T, Yamashita Y, Yamao T, Umezaki N, et al
    Hepatobiliary and Pancreatic: Hepatocellular carcinoma developed with angiomyolipoma.
    J Gastroenterol Hepatol. 2017;32:547.
    PubMed     Text format    


  89. HWANG HE, Tseng HS, Liu CA, Chiou YY, et al
    Hepatobiliary and Pancreatic: Obstructive jaundice after transarterial chemoembolization of hepatocellular carcinoma related to intraductal tumor necrotic fragment.
    J Gastroenterol Hepatol. 2017;32:546.
    PubMed     Text format    


  90. ZENG XQ, Ma LL, Tseng YJ, Chen J, et al
    Endoscopic cyanoacrylate injection with or without lauromacrogol for gastric varices: A randomized pilot study.
    J Gastroenterol Hepatol. 2017;32:631-638.
    PubMed     Text format     Abstract available


    February 2017
  91. KIRSTEIN MM, Schweitzer N, Winter T, Lappas K, et al
    Patterns and challenges of treatment sequencing in patients with hepatocellular carcinoma -experience from a referral center.
    J Gastroenterol Hepatol. 2017 Feb 10. doi: 10.1111/jgh.13761.
    PubMed     Text format     Abstract available


  92. LYON KC, Likar E, Martello JL, Regier M, et al
    Retrospective Cross-Sectional Pilot Study of Rifaximin Dosing for the Prevention of Recurrent Hepatic Encephalopathy.
    J Gastroenterol Hepatol. 2017 Feb 8. doi: 10.1111/jgh.13759.
    PubMed     Text format     Abstract available


  93. SAWAHARA H, Shiraha H, Uchida D, Kato H, et al
    Promising therapeutic efficacy of a novel REIC/Dkk-3 expressing adenoviral vector for hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2017 Feb 6. doi: 10.1111/jgh.13757.
    PubMed     Text format     Abstract available


  94. YOOPRASERT S, Thanapirom K, Treeprasertsuk S, Kullavanijaya P, et al
    Hepatobiliary and Pancreatic: Epstein-Barr virus-associated smooth muscle tumors: Unusual cause of hepatic mass in AIDS patient.
    J Gastroenterol Hepatol. 2017;32:293.
    PubMed     Text format    


  95. CHUNG SM, Kim KH, Kim KO, Kim TN, et al
    Hepatobiliary and Pancreatic: Hepatic portal vein gas accompanied by acute enterocolitis improved with non-surgical treatment.
    J Gastroenterol Hepatol. 2017;32:294.
    PubMed     Text format    


  96. ROBERTSON M, Watanabe M
    JGH OPEN: A new open access journal for gastroenterology and hepatology.
    J Gastroenterol Hepatol. 2017;32:289.
    PubMed     Text format    


  97. CHONG CC, Wong GL, Chan AW, Wong VW, et al
    Liver stiffness measurement predicts high-grade post-hepatectomy liver failure: A prospective cohort study.
    J Gastroenterol Hepatol. 2017;32:506-514.
    PubMed     Text format     Abstract available


  98. SHI KQ, Cai YJ, Lin Z, Dong JZ, et al
    Development and validation of a prognostic nomogram for acute-on-chronic hepatitis B liver failure.
    J Gastroenterol Hepatol. 2017;32:497-505.
    PubMed     Text format     Abstract available


    January 2017
  99. SEKI A, Ikeda F, Miyatake H, Takaguchi K, et al
    Risk of secondary osteoporosis due to lobular cholestasis in non-cirrhotic primary biliary cholangitis.
    J Gastroenterol Hepatol. 2017 Jan 23. doi: 10.1111/jgh.13746.
    PubMed     Text format     Abstract available


  100. ZHOU D, Pan Q, Liu XL, Yang RX, et al
    Clostridium butyricum B1 alleviates high-fat diet-induced steatohepatitis in mice via enterohepatic immunoregulation.
    J Gastroenterol Hepatol. 2017 Jan 20. doi: 10.1111/jgh.13742.
    PubMed     Text format     Abstract available


  101. POLLOCK G, Minuk GY
    Diagnostic Considerations for Cholestatic Liver Disease.
    J Gastroenterol Hepatol. 2017 Jan 20. doi: 10.1111/jgh.13738.
    PubMed     Text format     Abstract available


  102. XUE R, Feng J, Meng Q, Lv F, et al
    The Significance of Glypican-3 Expression Profiling in the Tumor Cellular Origin Theoretical System for Hepatocellular Carcinoma Progression.
    J Gastroenterol Hepatol. 2017 Jan 14. doi: 10.1111/jgh.13736.
    PubMed     Text format     Abstract available


  103. LEE SJ, Kim SU, Kim MD, Kim YH, et al
    Comparison of treatment outcomes between balloon-occluded retrograde transvenous obliteration and transjugular intrahepatic portosystemic shunt for gastric variceal bleeding hemostasis.
    J Gastroenterol Hepatol. 2017 Jan 13. doi: 10.1111/jgh.13729.
    PubMed     Text format     Abstract available


  104. SI T, Chen Y, Ma D, Gong X, et al
    Transarterial chemoembolization prior to liver transplantation for patients with hepatocellular carcinoma: a meta-analysis.
    J Gastroenterol Hepatol. 2017 Jan 13. doi: 10.1111/jgh.13727.
    PubMed     Text format     Abstract available


  105. WANG Y, Huang W, Li R, Yun Z, et al
    Systematic Quantitation of Histologic Patterns Shows Accuracy in Reflecting Cirrhotic Remodeling.
    J Gastroenterol Hepatol. 2017 Jan 9. doi: 10.1111/jgh.13722.
    PubMed     Text format     Abstract available


  106. REY S, Quintavalle C, Burmeister K, Calabrese D, et al
    LIVER DAMAGE AND SENESCENCE INCREASES IN PATIENTS DEVELOPING HEPATOCELLULAR CARCINOMA.
    J Gastroenterol Hepatol. 2017 Jan 3. doi: 10.1111/jgh.13717.
    PubMed     Text format     Abstract available


  107. BHAMIDIMARRI KR, Lanza DC, Kashikar ND
    Hepatobiliary and Pancreatic: A unique case of HPV related metastatic Schneiderian carcinoma presenting as polycystic liver disease.
    J Gastroenterol Hepatol. 2017;32:10.
    PubMed     Text format    


  108. SANO I, Kuwatani M, Sugiura R, Kato S, et al
    Hepatobiliary and Pancreatic: A rare case of a well-differentiated neuroendocrine tumor in the bile duct with spontaneous regression diagnosed by EUS-FNA.
    J Gastroenterol Hepatol. 2017;32:11.
    PubMed     Text format    


  109. RATHOD K, Deshmukh H, Shukla A, Popat B, et al
    Endovascular treatment of Budd-Chiari syndrome: Single center experience.
    J Gastroenterol Hepatol. 2017;32:237-243.
    PubMed     Text format     Abstract available


  110. CHOI HJ, Moon JH, Kim HK, Lee YN, et al
    KRAS mutation analysis by next-generation sequencing in endoscopic ultrasound-guided sampling for solid liver masses.
    J Gastroenterol Hepatol. 2017;32:154-162.
    PubMed     Text format     Abstract available


    December 2016
  111. BEKKI Y, Yoshizumi T, Shimoda S, Itoh S, et al
    Hepatic stellate cells secrete WFA+ -M2BP; its role in biological interactions with Kupffer cells.
    J Gastroenterol Hepatol. 2016 Dec 22. doi: 10.1111/jgh.13708.
    PubMed     Text format     Abstract available


  112. WANG C, Li G, Li J, Li J, et al
    Overexpression of the metastasis-associated gene MTA3 correlates with tumor progression and poor prognosis in hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2016 Dec 19. doi: 10.1111/jgh.13680.
    PubMed     Text format     Abstract available


  113. ZHAO Q, Zhang GL, Zhu X, Su D, et al
    The paradoxical changes of membrane and soluble herpes virus entry mediator in hepatocellular carcinoma patients.
    J Gastroenterol Hepatol. 2016 Dec 16. doi: 10.1111/jgh.13678.
    PubMed     Text format     Abstract available


  114. HUANG TS, Lin CL, Shyu YC, Yeh CT, et al
    Diabetes, hepatocellular carcinoma, and mortality in hepatitis C-infected patients: a population-based cohort study.
    J Gastroenterol Hepatol. 2016 Dec 8. doi: 10.1111/jgh.13670.
    PubMed     Text format     Abstract available


  115. RANA SS, Sharma R, Sharma V, Dhalaria L, et al
    Hepatobiliary and Pancreatic: Unusual space occupying lesion of liver.
    J Gastroenterol Hepatol. 2016;31:1916.
    PubMed     Text format    


  116. CHETCUTI ZAMMIT S, Chircop A, Cortis K, Pullicino E, et al
    Hepatobiliary and Pancreatic: Congenital intrahepatic portosystemic venous shunting: A great mimicker of liver cirrhosis.
    J Gastroenterol Hepatol. 2016;31:1917.
    PubMed     Text format    


    November 2016
  117. SHARMA BC, Singh J, Srivastava S, Sangam A, et al
    A Randomized Controlled Trial Comparing Lactulose Plus Albumin versus Lactulose alone for Treatment of Hepatic Encephalopathy.
    J Gastroenterol Hepatol. 2016 Nov 25. doi: 10.1111/jgh.13666.
    PubMed     Text format     Abstract available


  118. PARK JH, Lee DH, Park MS, Jung YS, et al
    CCR5 deficiency exacerbates alcoholic fatty liver disease through pro-inflammatory cytokines and chemokines-induced hepatic inflammation.
    J Gastroenterol Hepatol. 2016 Nov 17. doi: 10.1111/jgh.13657.
    PubMed     Text format     Abstract available


  119. KIM JH, Sinn DH, Gwak GY, Kang W, et al
    Insulin resistance assessment is useful in risk stratification of hepatocellular carcinoma in chronic hepatitis B patients.
    J Gastroenterol Hepatol. 2016 Nov 11. doi: 10.1111/jgh.13647.
    PubMed     Text format     Abstract available


  120. LEE YR, Park SY, Kim SU, Jang SY, et al
    Using transient elastography to predict hepatocellular carcinoma recurrence after radiofrequency ablation.
    J Gastroenterol Hepatol. 2016 Nov 10. doi: 10.1111/jgh.13644.
    PubMed     Text format     Abstract available


  121. BUSK TM, Moller S, Pedersen EB, Gerbes A, et al
    Aquaporin-2 Excretion in Hospitalized Patients with Cirrhosis: Relation to Development of Renal Insufficiency and Mortality.
    J Gastroenterol Hepatol. 2016 Nov 7. doi: 10.1111/jgh.13641.
    PubMed     Text format     Abstract available


  122. SUN H, Song J, Weng C, Xu J, et al
    Decreased expression of the macrophage scavenger receptor MARCO is associated with tumour progression and poor prognosis in human hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2016 Nov 2. doi: 10.1111/jgh.13633.
    PubMed     Text format     Abstract available


  123. HU HJ, Jing QY, Cheng NS, Li FY, et al
    Hepatobiliary and Pancreatic: A hepatic mass involving diaphragm: A real malignancy?
    J Gastroenterol Hepatol. 2016;31:1801.
    PubMed     Text format    


    October 2016
  124. LEE EC, Kim SH, Park H, Lee SD, et al
    Survival Analysis after Liver Resection for Hepatocellular Carcinoma: A Consecutive Cohort of 1002 Patients.
    J Gastroenterol Hepatol. 2016 Oct 31. doi: 10.1111/jgh.13632.
    PubMed     Text format     Abstract available


  125. INOUE M, Ogasawara S, Chiba T, Ooka Y, et al
    Presence of non-hypervascular hypointense nodules on Gd-EOB-DTPA enhanced MRI in patients with hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2016 Oct 27. doi: 10.1111/jgh.13622.
    PubMed     Text format     Abstract available


  126. WARNE CD, Zaloumis SG, Bertalli NA, Delatycki MB, et al
    HFE p.C282Y homozygosity predisposes to rapid serum ferritin rise after menopause: a genotype-stratified cohort study of hemochromatosis in Australian women.
    J Gastroenterol Hepatol. 2016 Oct 26. doi: 10.1111/jgh.13621.
    PubMed     Text format     Abstract available


  127. AHN JM, Kim CH, Um SH, Kim KM, et al
    A validation Study Associating Glutaminase Promoter Variations with Hepatic Encephalopathy in East Asian Populations.
    J Gastroenterol Hepatol. 2016 Oct 17. doi: 10.1111/jgh.13618.
    PubMed     Text format     Abstract available


  128. MINAKARI M, Badihian S, Jalalpour P, Sebghatollahi V, et al
    Etiology and outcome in patients with upper gastrointestinal bleeding: Study on 4747 patients in the central region of Iran.
    J Gastroenterol Hepatol. 2016 Oct 17. doi: 10.1111/jgh.13617.
    PubMed     Text format     Abstract available



  129. Hepatology Clinical.
    J Gastroenterol Hepatol. 2016;31 Suppl 2:89-120.
    PubMed     Text format    


    September 2016
  130. ZHAO H, Chen C, Gu S, Yan X, et al
    Anatomical versus non-anatomical resection for solitary hepatocellular carcinoma without macroscopic vascular invasion: A propensity score matching analysis.
    J Gastroenterol Hepatol. 2016 Sep 26. doi: 10.1111/jgh.13603.
    PubMed     Text format     Abstract available


  131. LIU P, Qiu Y, Qian Y, Chen X, et al
    Quality of Meta-analyses in Major Leading Gastroenterology and Hepatology Journals: A Systematic Review.
    J Gastroenterol Hepatol. 2016 Sep 6. doi: 10.1111/jgh.13591.
    PubMed     Text format     Abstract available


  132. NOUSO K, Kariyama K, Nakamura S, Oonishi A, et al
    Application of Radiofrequency Ablation for the Treatment of Intermediate-Stage Hepatocellular Carcinoma.
    J Gastroenterol Hepatol. 2016 Sep 6. doi: 10.1111/jgh.13586.
    PubMed     Text format     Abstract available


    August 2016
  133. CHAN AW, Wong GL, Chan HY, Tong JH, et al
    Concurrent fatty liver increases risk of hepatocellular carcinoma among patients with chronic hepatitis B.
    J Gastroenterol Hepatol. 2016 Aug 22. doi: 10.1111/jgh.13536.
    PubMed     Text format     Abstract available


  134. CHOI SI, Yu A, Kim BH, Ko EJ, et al
    A Model Predicting Survival of Patients with Recurrent or Progressive Hepatocellular Carcinoma: The MORE Score.
    J Gastroenterol Hepatol. 2016 Aug 12. doi: 10.1111/jgh.13532.
    PubMed     Text format     Abstract available


  135. HU HT, Yao QJ, Meng YL, Li HL, et al
    Arsenic trioxide intravenous infusion combined with transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with pulmonary metastasis: long-term outcome analysis.
    J Gastroenterol Hepatol. 2016 Aug 12. doi: 10.1111/jgh.13529.
    PubMed     Text format     Abstract available


  136. MORIO K, Imamura M, Kawakami Y, Morio R, et al
    Real-World Efficacy and Safety of Daclatasvir and Asunaprevir Therapy for Hepatitis C Virus-Infected Cirrhosis Patients.
    J Gastroenterol Hepatol. 2016 Aug 11. doi: 10.1111/jgh.13511.
    PubMed     Text format     Abstract available


  137. LEE YK, Jung KS, Kim DY, Choi JY, et al
    Tumor size might not distinguish outcomes between conventional and drug-eluting chemoembolization for hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2016 Aug 9. doi: 10.1111/jgh.13501.
    PubMed     Text format     Abstract available


    July 2016
  138. PARK TY, Lee SK, Nam K, Oh D, et al
    Spontaneous hemobilia after liver transplantation: frequency, risk factors, and outcome of endoscopic management.
    J Gastroenterol Hepatol. 2016 Jul 23. doi: 10.1111/jgh.13497.
    PubMed     Text format     Abstract available


  139. RUDNICKA A, Woziwodzka A, Wroblewska A, Rybicka M, et al
    Analysis of polymorphism and hepatic expression of duodenal cytochrome b in chronic hepatitis C.
    J Gastroenterol Hepatol. 2016 Jul 20. doi: 10.1111/jgh.13495.
    PubMed     Text format     Abstract available


  140. HURRY PK, Poulsen JH, Bendtsen F, Moller S, et al
    Neutrophil gelatinase associated lipocalin and Cystatin C in cirrhosis and portal hypertension: Relations to organ extraction and dysfunction.
    J Gastroenterol Hepatol. 2016 Jul 20. doi: 10.1111/jgh.13492.
    PubMed     Text format     Abstract available


  141. LEBRETON A, Sinegre T, Pereira B, Lamblin G, et al
    Plasma hypercoagulability in the presence of thrombomodulin but not of activated protein C in patients with cirrhosis.
    J Gastroenterol Hepatol. 2016 Jul 15. doi: 10.1111/jgh.13493.
    PubMed     Text format     Abstract available


    June 2016
  142. LIANG XE, Zhong C, Huang L, Yang S, et al
    Stepwise Application of Transient Elastography and Routine Biomarkers Optimizes Hepatitis B Cirrhosis Detection.
    J Gastroenterol Hepatol. 2016 Jun 26. doi: 10.1111/jgh.13475.
    PubMed     Text format     Abstract available


  143. CHAN AW, Chong CC, Mo FK, Wong J, et al
    Incorporating Albumin-Bilirubin grade into the Cancer of the Liver Italian Program system for hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2016 Jun 2. doi: 10.1111/jgh.13457.
    PubMed     Text format     Abstract available


    May 2016
  144. TSAI WL, Yeh PH, Tsai CY, Ting CT, et al
    Efficient Programming of Human Mesenchymal Stem Cell Derived Hepatocytes by Epigenetic Regulations.
    J Gastroenterol Hepatol. 2016 May 24. doi: 10.1111/jgh.13451.
    PubMed     Text format     Abstract available


  145. NOVEIRY BB, Hirbod-Mobarakeh A, Khalili N, Hourshad N, et al
    Specific immunotherapy in Hepatocellular cancer: a Systematic Review.
    J Gastroenterol Hepatol. 2016 May 21. doi: 10.1111/jgh.13449.
    PubMed     Text format     Abstract available


  146. KIM SS, Nam JS, Cho HJ, Won JH, et al
    Plasma micoRNA-122 as a predictive marker for treatment response following transarterial chemoembolization in patients with hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2016 May 18. doi: 10.1111/jgh.13448.
    PubMed     Text format     Abstract available


  147. CHOLONGITAS E, Ioannidou M, Goulis I, Chalevas P, et al
    Comparison of Creatinine and Cystatin Formulae with 51 Chromium-Edta Glomerular Filtration Rate in Patients With Decompensated Cirrhosis.
    J Gastroenterol Hepatol. 2016 May 13. doi: 10.1111/jgh.13446.
    PubMed     Text format     Abstract available


  148. PATERNOSTRO R, Reiberger T, Mandorfer M, Schwarzer R, et al
    Plasma renin concentration represents an independent risk factor for mortality and is associated with liver dysfunction in patients with cirrhosis.
    J Gastroenterol Hepatol. 2016 May 10. doi: 10.1111/jgh.13439.
    PubMed     Text format     Abstract available


  149. PHAN VA, Abu-Assi R, Nguyen N
    Utility of per-oral cholangioscopy in the diagnosis of portal hypertension associated biliopathy.
    J Gastroenterol Hepatol. 2016 May 10. doi: 10.1111/jgh.13442.
    PubMed     Text format    


  150. LIU J, Wang J, Jin D, Qi C, et al
    Hepatic flare after telbivudine withdrawal and efficacy of postpartum antiviral therapy for pregnancies with chronic HBV.
    J Gastroenterol Hepatol. 2016 May 9. doi: 10.1111/jgh.13436.
    PubMed     Text format     Abstract available


  151. OGURA T, Onda S, Takagi W, Sano T, et al
    Clinical utility of Endoscopic ultrasound-guided biliary drainage as a rescue of re-intervention procedure for high-grade hilar stricture.
    J Gastroenterol Hepatol. 2016 May 9. doi: 10.1111/jgh.13437.
    PubMed     Text format     Abstract available


  152. KUTTING F, Schubert J, Franklin J, Bowe A, et al
    Insufficient evidence of benefit regarding mortality due to albumin substitution in HCC-free cirrhotic patients undergoing large volume paracentesis.
    J Gastroenterol Hepatol. 2016 May 3. doi: 10.1111/jgh.13421.
    PubMed     Text format     Abstract available


  153. LAI YC, Wu P, Huang CC, Wu CH, et al
    Intra-hepatic arterio-biliary fistula complicated by blunt abdomen trauma demonstrated at angiogram.
    J Gastroenterol Hepatol. 2016 May 1. doi: 10.1111/jgh.13433.
    PubMed     Text format    


  154. LUANGSUKRERKA T, Aumpansuba P, Chaiteerakija R
    Liver abscesso-colonic fistula: A rare complication of transarterial chemoembolization for treatment of hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2016 May 1. doi: 10.1111/jgh.13431.
    PubMed     Text format    


    April 2016
  155. XU X, Li B, Zheng C
    Acute acalculous cholecystitis in systemic lupus erythematosus.
    J Gastroenterol Hepatol. 2016 Apr 30. doi: 10.1111/jgh.13430.
    PubMed     Text format    


  156. K YADAV S, Goel A, A Saraswat V, A Thomas M, et al
    Evaluation of Cognitivity, Proinflammatory Cytokines, and Brain MRI in Minimal Hepatic Encephalopathy induced by Cirrhosis and EHPVO.
    J Gastroenterol Hepatol. 2016 Apr 27. doi: 10.1111/jgh.13427.
    PubMed     Text format     Abstract available


  157. ZHANG P, Yang Y, Wen F, Wheeler J, et al
    Cost-effectiveness analysis of antiviral therapy in patients with advanced hepatitis B virus-related hepatocellular carcinoma treated with sorafenib.
    J Gastroenterol Hepatol. 2016 Apr 27. doi: 10.1111/jgh.13425.
    PubMed     Text format     Abstract available


  158. CHIEN J, Liu J, Lee MH, Jen CL, et al
    Risk and Predictors of Hepatocellular Carcinoma for Chronic Hepatitis b Patients With Newly Developed Cirrhosis.
    J Gastroenterol Hepatol. 2016 Apr 26. doi: 10.1111/jgh.13422.
    PubMed     Text format     Abstract available


  159. TARDELLI M, Moreno-Viedma V, Zeyda M, Itariu BK, et al
    Adiponectin regulates aquaglyceroporin expression in hepatic stellate cells altering their functional state.
    J Gastroenterol Hepatol. 2016 Apr 15. doi: 10.1111/jgh.13415.
    PubMed     Text format     Abstract available


  160. SHEPTULINA A, Shirokova E, Nekrasova T, Blum H, et al
    Platelet count to spleen diameter ratio non-invasively identifies severe fibrosis and cirrhosis in patients with autoimmune hepatitis.
    J Gastroenterol Hepatol. 2016 Apr 5. doi: 10.1111/jgh.13407.
    PubMed     Text format     Abstract available


  161. GUO B, Li D
    A hepatic space-occupying lesion in a woman of childbearing age.
    J Gastroenterol Hepatol. 2016 Apr 4. doi: 10.1111/jgh.13396.
    PubMed     Text format     Abstract available


  162. KUROKAWA T, Zheng YW, Ohkohchi N
    Novel functions of platelets in the liver.
    J Gastroenterol Hepatol. 2016;31:745-51.
    PubMed     Text format     Abstract available


  163. TSENG CM, Chuang HW, Tai CM
    EDUCATION AND IMAGING. Gastrointestinal: Duodenal metastatic epithelioid angiosarcoma.
    J Gastroenterol Hepatol. 2016;31:705.
    PubMed     Text format    


  164. DE LEDINGHEN V, Wong GL, Vergniol J, Chan HL, et al
    Controlled attenuation parameter for the diagnosis of steatosis in non-alcoholic fatty liver disease.
    J Gastroenterol Hepatol. 2016;31:848-55.
    PubMed     Text format     Abstract available


  165. DONG Y, Wang WP, Mao F, Ji ZB, et al
    Application of imaging fusion combining contrast-enhanced ultrasound and magnetic resonance imaging in detection of hepatic cellular carcinomas undetectable by conventional ultrasound.
    J Gastroenterol Hepatol. 2016;31:822-8.
    PubMed     Text format     Abstract available


    March 2016
  166. WU W, Zhang J, Yang W, Hu B, et al
    The role of splenic reservoir monocytes in pulmonary vascular monocyte accumulation in experimental hepatopulmonary syndrome.
    J Gastroenterol Hepatol. 2016 Mar 31. doi: 10.1111/jgh.13388.
    PubMed     Text format     Abstract available


  167. CHAN WK, Wong VW
    Oxidized low-density lipoprotein in non-alcoholic steatohepatitis.
    J Gastroenterol Hepatol. 2016 Mar 25. doi: 10.1111/jgh.13381.
    PubMed     Text format    


  168. KAO JH, Tung SY, Lee Y, Thongsawat S, et al
    Ritonavir-boosted danoprevir plus peginterferon alfa-2a and ribavirin in Asian chronic hepatitis C patients with or without cirrhosis.
    J Gastroenterol Hepatol. 2016 Mar 19. doi: 10.1111/jgh.13374.
    PubMed     Text format     Abstract available


  169. MAAN R, Zaim R, van der Meer AJ, Feld JJ, et al
    Real-world medical costs of antiviral therapy among patients with chronic HCV infection and advanced hepatic fibrosis.
    J Gastroenterol Hepatol. 2016 Mar 18. doi: 10.1111/jgh.13373.
    PubMed     Text format     Abstract available


  170. CHAN AW, Chong CC, Mo FK, Wong J, et al
    Applicability of Albumin-Bilirubin-based Japan Integrated Staging (ALBI-T) score in hepatitis B-associated hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2016 Mar 15. doi: 10.1111/jgh.13339.
    PubMed     Text format     Abstract available


  171. KIM JW, Seong J, Park MS, Kim KS, et al
    Radiological-pathological correlation study of hepatocellular carcinoma undergoing local chemoradiotherapy and surgery.
    J Gastroenterol Hepatol. 2016 Mar 10. doi: 10.1111/jgh.13334.
    PubMed     Text format     Abstract available


  172. HU Y, Zhang H, Li J, Cong X, et al
    Gut-derived lymphocyte recruitment to liver and induce liver injury in non-alcoholic fatty liver disease mouse model.
    J Gastroenterol Hepatol. 2016;31:676-84.
    PubMed     Text format     Abstract available


  173. SINCLAIR M, Grossmann M, Angus PW, Hoermann R, et al
    Low testosterone as a better predictor of mortality than sarcopenia in men with advanced liver disease.
    J Gastroenterol Hepatol. 2016;31:661-7.
    PubMed     Text format     Abstract available


  174. HEEBOLL S, El-Houri RB, Hellberg YE, Haldrup D, et al
    Effect of resveratrol on experimental non-alcoholic fatty liver disease depends on severity of pathology and timing of treatment.
    J Gastroenterol Hepatol. 2016;31:668-75.
    PubMed     Text format     Abstract available


    February 2016
  175. JIN YJ, Lee SH, Cho SG, Kim JH, et al
    Prediction of Postoperative Liver Failure using Gadoxetic Acid-enhanced Magnetic Resonance Imaging in Patients with Hepatocellular Carcinoma.
    J Gastroenterol Hepatol. 2016 Feb 24. doi: 10.1111/jgh.13327.
    PubMed     Text format     Abstract available


  176. KAIDA T, Higashi T, Kitano Y, Yamamura K, et al
    Degenerative hepatic hemangioma mimicking biliary cystadenocarcinoma.
    J Gastroenterol Hepatol. 2016 Feb 20. doi: 10.1111/jgh.13325.
    PubMed     Text format    


  177. FRIEDRICH K, Smit M, Wannhoff A, Rupp C, et al
    Coffee consumption protects against progression in liver cirrhosis and increases long-term survival after liver transplantation.
    J Gastroenterol Hepatol. 2016 Feb 15. doi: 10.1111/jgh.13319.
    PubMed     Text format     Abstract available


  178. LIU H, Liu J, Zhang Y, Liao J, et al
    Contrast-enhanced ultrasound and CT perfusion imaging of a liver fibrosis-early cirrhosis in dogs.
    J Gastroenterol Hepatol. 2016 Feb 15. doi: 10.1111/jgh.13320.
    PubMed     Text format     Abstract available


  179. NISHIDA N, Yada N, Hagiwara S, Sakurai T, et al
    Unique features associated with hepatic oxidative DNA damage and DNA methylation in non-alcoholic fatty liver disease.
    J Gastroenterol Hepatol. 2016 Feb 15. doi: 10.1111/jgh.13318.
    PubMed     Text format     Abstract available


  180. ZHANG AY, Lai CL, Poon RT, Huang FY, et al
    Hepatitis B virus full-length genomic mutations and quasispecies in hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2016 Feb 15. doi: 10.1111/jgh.13316.
    PubMed     Text format     Abstract available


  181. PELUCCHI S, Galimberti S, Greni F, Rametta R, et al
    Proprotein convertase 7 rs236918 is associated with liver fibrosis in Italian patients with HFE-related Hemochromatosis.
    J Gastroenterol Hepatol. 2016 Feb 11. doi: 10.1111/jgh.13315.
    PubMed     Text format     Abstract available


  182. SHAO YY, Liu TH, Lee YH, Hsu CH, et al
    Modified CLIP with objective liver reserve assessment retains prognosis prediction for patients with advanced hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2016 Feb 9. doi: 10.1111/jgh.13312.
    PubMed     Text format     Abstract available


  183. HALABI SA, Sawas T, Sadat B, Jandali A, et al
    Early TIPS Versus Endoscopic Therapy for Secondary Prophylaxis After Management of Acute Esophageal Variceal Bleeding in Cirrhotic Patients: A Meta-Analysis of Randomized Controlled Trials.
    J Gastroenterol Hepatol. 2016 Feb 9. doi: 10.1111/jgh.13303.
    PubMed     Text format     Abstract available


  184. LU C, Wang K, Zhang CZ, Zhou FG, et al
    The outcomes of intrahepatic cholangiocarcinoma with portal vein tumor thrombus following hepatic resection.
    J Gastroenterol Hepatol. 2016 Feb 8. doi: 10.1111/jgh.13309.
    PubMed     Text format     Abstract available


  185. KIM HY, Chang Y, Park JY, Ahn H, et al
    Characterization of acute-on-chronic liver failure and prediction of mortality in Asian patients with active alcoholism.
    J Gastroenterol Hepatol. 2016;31:427-33.
    PubMed     Text format     Abstract available


  186. CHEN RX, Gan YH, Ge NL, Chen Y, et al
    Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching.
    J Gastroenterol Hepatol. 2016;31:442-9.
    PubMed     Text format     Abstract available


  187. SASAKI H, Murakami Y, Uemura K, Hashimoto Y, et al
    EDUCATION AND IMAGING. Hepatobiliary and Pancreatic: Long-term survival of serous cystadenocarcinoma of the pancreas with synchronous liver metastases after aggressive surgical resection.
    J Gastroenterol Hepatol. 2016;31:287.
    PubMed     Text format    


    January 2016
  188. SATO S, Genda T, Ichida T, Murata A, et al
    Impact of aldo-keto reductase family 1 member B10 on the risk of hepatitis C virus-related hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2016 Jan 13. doi: 10.1111/jgh.13295.
    PubMed     Text format     Abstract available


  189. CHAN AW, Kumada T, Toyoda H, Tada T, et al
    Integration of albumin-bilirubin (ALBI) score into Barcelona clinic liver cancer (BCLC) system for hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2016 Jan 9. doi: 10.1111/jgh.13291.
    PubMed     Text format     Abstract available


  190. CHUA TC, Roseverne LO, Goh AC, Maher R, et al
    Hepatobiliary and Pancreatic: Dual system stenting of the biliary and porto-venous systems to palliate locoregional recurrence of hilar cholangiocarcinoma.
    J Gastroenterol Hepatol. 2016 Jan 5. doi: 10.1111/jgh.13285.
    PubMed     Text format    


  191. EL SEBAY HM, Safan MA, Daoud AA, Tayel SI, et al
    Association of factor V Leiden, Janus kinase 2, prothrombin, and MTHFR mutations with primary Budd-Chiari syndrome in Egyptian patients.
    J Gastroenterol Hepatol. 2016;31:235-40.
    PubMed     Text format     Abstract available


  192. KAPIL S, Duseja A, Sharma BK, Singla B, et al
    Small intestinal bacterial overgrowth and toll-like receptor signaling in patients with non-alcoholic fatty liver disease.
    J Gastroenterol Hepatol. 2016;31:213-21.
    PubMed     Text format     Abstract available


  193. CHEN JP, Peng B, Tang L, Sun R, et al
    Fetal and infant exposure to the Chinese famine increases the risk of fatty liver disease in Chongqing, China.
    J Gastroenterol Hepatol. 2016;31:200-5.
    PubMed     Text format     Abstract available


  194. CARBONE LJ, Angus PW, Yeomans ND
    Incretin-based therapies for the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    J Gastroenterol Hepatol. 2016;31:23-31.
    PubMed     Text format     Abstract available


  195. DING PX, Zhang SJ, Li Z, Fu MT, et al
    Long-term safety and outcome of percutaneous transhepatic venous balloon angioplasty for Budd-Chiari syndrome.
    J Gastroenterol Hepatol. 2016;31:222-8.
    PubMed     Text format     Abstract available


    December 2015
  196. SINGH J, Sharma BC, Maharshi S, Puri V, et al
    Spectral electroencephalogram in liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy.
    J Gastroenterol Hepatol. 2015 Dec 30. doi: 10.1111/jgh.13283.
    PubMed     Text format     Abstract available


  197. CHEN J, Fan X, Zhou L, Gao X, et al
    Treatment with geraniol ameliorates methionine-choline deficient diet-induced nonalcoholic steatohepatitis in rats.
    J Gastroenterol Hepatol. 2015 Dec 22. doi: 10.1111/jgh.13272.
    PubMed     Text format     Abstract available


  198. EATON JE, Dzyubak B, Venkatesh SK, Smyrk TC, et al
    Performance of magnetic resonance elastography in primary sclerosing cholangitis.
    J Gastroenterol Hepatol. 2015 Dec 21. doi: 10.1111/jgh.13263.
    PubMed     Text format     Abstract available


  199. FUNG AC, Chok KS, Lo AW, Lo CM, et al
    Hepatic splenosis - a rare differential in an HBV endemic area.
    J Gastroenterol Hepatol. 2015 Dec 20. doi: 10.1111/jgh.13275.
    PubMed     Text format    


  200. VAN DER MEER AJ, Maan R, Veldt BJ, Feld JJ, et al
    Improvement of platelets after SVR among patients with chronic HCV infection and advanced hepatic fibrosis.
    J Gastroenterol Hepatol. 2015 Dec 8. doi: 10.1111/jgh.13252.
    PubMed     Text format     Abstract available


  201. HIRAOKA A, Kumada T, Michitaka K, Toyoda H, et al
    Usefulness of albumin-bilirubin (ALBI) grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2015 Dec 8. doi: 10.1111/jgh.13250.
    PubMed     Text format     Abstract available


  202. QIN B, Wei T, Wang L, Ma N, et al
    Decreased expression of TIPE2 contributes to the hyper-reactivity of monocyte to TLR ligands in primary biliary cirrhosis.
    J Gastroenterol Hepatol. 2015 Dec 8. doi: 10.1111/jgh.13251.
    PubMed     Text format     Abstract available


  203. GAETANO JN, Micic D, Aronsohn A, Reddy G, et al
    The benefit of paracentesis on hospitalized adults with cirrhosis and ascites.
    J Gastroenterol Hepatol. 2015 Dec 8. doi: 10.1111/jgh.13255.
    PubMed     Text format     Abstract available


  204. WANG YB, Zhang JY, Gong JP, Zhang F, et al
    Balloon-occluded retrograde transvenous obliteration versus transjugular intrahepatic portosystemic shunt for treatment of gastric varices due to portal hypertension: A meta-analysis.
    J Gastroenterol Hepatol. 2015 Dec 5. doi: 10.1111/jgh.13248.
    PubMed     Text format     Abstract available


  205. DAITOKU N, Okabe H, Hashimoto D, Chikamoto A, et al
    Hepatobiliary and Pancreatic: Replaced common hepatic artery on left gastric artery: a rare anomaly and implication for pancreaticoduodenectomy.
    J Gastroenterol Hepatol. 2015;30:1695.
    PubMed     Text format    


  206. NEPAL P, Kumar D, Ramanathan S, Faki A, et al
    Hepatobiliary and Pancreatic: Gall bladder duplication presenting with gall-stone pancreatitis: Use of hepatobiliary specific MRCP in preoperative evaluation of ductal anatomy.
    J Gastroenterol Hepatol. 2015;30:1694.
    PubMed     Text format    


    November 2015
  207. LAI WJ, Chiu NC, Chau GY
    Hepatobiliary and pancreatic: Unusual enhancing tumor in hepatitis B carrier.
    J Gastroenterol Hepatol. 2015 Nov 24. doi: 10.1111/jgh.13237.
    PubMed     Text format    


  208. GASSIEP I, Clark PJ, McManus DP, Looke DL, et al
    Hepatobiliary and Pancreatic: Acute hepatitis in the setting of chronic schistosoma mansoni infection and post- praziquantel therapy.
    J Gastroenterol Hepatol. 2015 Nov 24. doi: 10.1111/jgh.13239.
    PubMed     Text format    


  209. MAIWALL R, Kumar S, Sharma MK, Wani Z, et al
    Prevalence and prognostic significance of hyperkalemia in hospitalized patients with cirrhosis.
    J Gastroenterol Hepatol. 2015 Nov 24. doi: 10.1111/jgh.13243.
    PubMed     Text format     Abstract available


  210. ADAMS LA, Arauz O, Angus PW, Sinclair M, et al
    The additive impact of pre-liver transplant metabolic factors on survival post-liver transplant.
    J Gastroenterol Hepatol. 2015 Nov 21. doi: 10.1111/jgh.13240.
    PubMed     Text format     Abstract available


  211. GOH GB, Issa D, Lopez R, Dasarathy S, et al
    The development of a non-invasive model to predict the presence of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease.
    J Gastroenterol Hepatol. 2015 Nov 20. doi: 10.1111/jgh.13235.
    PubMed     Text format     Abstract available


  212. NAGAOKI Y, Aikata H, Nakano N, Shinohara F, et al
    Development of hepatocellular carcinoma in patients with hepatitis C virus infection who achieved sustained virological response following interferon therapy: A large-scale, long-term cohort study.
    J Gastroenterol Hepatol. 2015 Nov 19. doi: 10.1111/jgh.13236.
    PubMed     Text format     Abstract available


  213. POK S, Barn VA, Wong HJ, Blackburn AC, et al
    Testosterone regulation of cyclin E kinase is a key factor determining gender differences in hepatocarcinogenesis.
    J Gastroenterol Hepatol. 2015 Nov 17. doi: 10.1111/jgh.13232.
    PubMed     Text format     Abstract available


  214. HIRAMATSU N, Yamada R, Takehara T
    The suppressive effect of nucleos(t)ide analogue treatment on the incidence of hepatocellular carcinoma in chronic hepatitis B patients.
    J Gastroenterol Hepatol. 2015 Nov 17. doi: 10.1111/jgh.13229.
    PubMed     Text format     Abstract available


  215. KIM Y, Lee EJ, Jang HK, Kim CH, et al
    Statin pretreatment inhibits the LPS-induced EMT via the downregulation of TLR4 and NF-kappaB in human biliary epithelial cells.
    J Gastroenterol Hepatol. 2015 Nov 17. doi: 10.1111/jgh.13230.
    PubMed     Text format     Abstract available


    October 2015
  216. WANG D, Wang Q, Yin J, Dong R, et al
    Combined administration of propranolol plus AG490 offers better effects on portal hypertensive rats with cirrhosis.
    J Gastroenterol Hepatol. 2015 Oct 21. doi: 10.1111/jgh.13207.
    PubMed     Text format     Abstract available


    June 2015
  217. TOMENO W, Kawashima K, Yoneda M, Saito S, et al
    Non-alcoholic fatty liver disease comorbid with major depressive disorder: The pathological features and poor therapeutic efficacy.
    J Gastroenterol Hepatol. 2015;30:1009-14.
    PubMed     Text format     Abstract available


  218. LIM S, Han J, Kim GM, Han KH, et al
    Hepatitis B viral load predicts survival in hepatocellular carcinoma patients treated with sorafenib.
    J Gastroenterol Hepatol. 2015;30:1024-31.
    PubMed     Text format     Abstract available


  219. SEKIMOTO T, Maruyama H, Kondo T, Shimada T, et al
    Potential stagnation in the splanchnic hemodynamics demonstrated by the dynamic microbubbles in chronic liver disease.
    J Gastroenterol Hepatol. 2015;30:1001-8.
    PubMed     Text format     Abstract available


    May 2015
  220. ZHANG L, You W, Zhang H, Peng R, et al
    PNPLA3 polymorphisms (rs738409) and non-alcoholic fatty liver disease risk and related phenotypes: a meta-analysis.
    J Gastroenterol Hepatol. 2015;30:821-9.
    PubMed     Text format     Abstract available


  221. KIMURA T, Deshpande GA, Urayama KY, Masuda K, et al
    Association of weight gain since age 20 with non-alcoholic fatty liver disease in normal weight individuals.
    J Gastroenterol Hepatol. 2015;30:909-17.
    PubMed     Text format     Abstract available


  222. KARRAR A, Stepanova M, Alaparthi L, Lingam S, et al
    Anti-adipocyte antibody response in patients with non-alcoholic fatty liver disease.
    J Gastroenterol Hepatol. 2015;30:900-8.
    PubMed     Text format     Abstract available


  223. YANG X, Miao R, Yang H, Chi T, et al
    Retrospective and comparative study of inflammatory myofibroblastic tumor of the liver.
    J Gastroenterol Hepatol. 2015;30:885-90.
    PubMed     Text format     Abstract available


    April 2015
  224. CHENG R, Cooper A, Kench J, Watson G, et al
    Ipilimumab-induced toxicities and the gastroenterologist.
    J Gastroenterol Hepatol. 2015;30:657-66.
    PubMed     Text format     Abstract available


  225. YE LC, Wei Y, Zhu DX, Chen T, et al
    Impact of early tumor shrinkage on clinical outcome in wild-type-KRAS colorectal liver metastases treated with cetuximab.
    J Gastroenterol Hepatol. 2015;30:674-9.
    PubMed     Text format     Abstract available


  226. JIA J, Hou J, Ding H, Chen G, et al
    Transient elastography compared to serum markers to predict liver fibrosis in a cohort of Chinese patients with chronic hepatitis B.
    J Gastroenterol Hepatol. 2015;30:756-62.
    PubMed     Text format     Abstract available


  227. CHOUDHARY NS, Saraf N, Saigal S, Gautam D, et al
    Estimation of normal values of serum transaminases based on liver histology in healthy Asian Indians.
    J Gastroenterol Hepatol. 2015;30:763-6.
    PubMed     Text format     Abstract available


  228. SHIN JY, Kim MJ, Kim ES, Mo EY, et al
    Association between serum calcium and phosphorus concentrations with non-alcoholic fatty liver disease in Korean population.
    J Gastroenterol Hepatol. 2015;30:733-41.
    PubMed     Text format     Abstract available


    February 2015
  229. CHANG ML, Hsu CM, Tseng JH, Tsou YK, et al
    Plasminogen activator inhibitor-1 is independently associated with non-alcoholic fatty liver disease whereas leptin and adiponectin vary between genders.
    J Gastroenterol Hepatol. 2015;30:329-36.
    PubMed     Text format     Abstract available


  230. GAO L, Ge C, Fang T, Zhao F, et al
    ANGPTL2 promotes tumor metastasis in hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2015;30:396-404.
    PubMed     Text format     Abstract available


  231. SONG CY, Zeng X, Wang Y, Shi J, et al
    Sophocarpine attenuates toll-like receptor 4 in steatotic hepatocytes to suppress pro-inflammatory cytokines synthesis.
    J Gastroenterol Hepatol. 2015;30:405-12.
    PubMed     Text format     Abstract available


  232. WANG JH, Kee KM, Lin CY, Hung CH, et al
    Validation and modification of a proposed substaging system for patients with intermediate hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2015;30:358-63.
    PubMed     Text format     Abstract available


  233. SINCLAIR M, Grossmann M, Gow PJ, Angus PW, et al
    Testosterone in men with advanced liver disease: abnormalities and implications.
    J Gastroenterol Hepatol. 2015;30:244-51.
    PubMed     Text format     Abstract available


  234. LIN ZY, Wu CC, Chuang YH, Chuang WL, et al
    Clinical utility of a simple primary culture method in hepatocellular carcinoma patients.
    J Gastroenterol Hepatol. 2015;30:352-7.
    PubMed     Text format     Abstract available


    January 2015
  235. DONG R, Zheng S
    Interleukin-8: A critical chemokine in biliary atresia.
    J Gastroenterol Hepatol. 2015 Jan 22. doi: 10.1111/jgh.12900.
    PubMed     Text format     Abstract available


    August 2014
  236. KASHIHARA H, Shimada M, Kurita N, Sato H, et al
    Duodenal-jejunal bypass improves diabetes and liver steatosis via enhanced glucagon-like peptide-1 elicited by bile acids.
    J Gastroenterol Hepatol. 2014 Aug 4. doi: 10.1111/jgh.12690.
    PubMed     Text format     Abstract available


  237. OGASAWARA S, Akiba J, Nakayama M, Nakashima O, et al
    Epithelial cell adhesion molecule-positive human hepatic neoplastic cells can develop combined hepatocellular-cholangiocarcinoma in mice.
    J Gastroenterol Hepatol. 2014 Aug 4. doi: 10.1111/jgh.12692.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: